Waseem Hajjar | Clinical Medicine | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Waseem Hajjar — King Saud University, Saudi Arabia

Researcher Profile
Researcher Waseem Hajjar
Affiliation King Saud University
Country Saudi Arabia
Scopus ID 35518559800
Documents 76
Citations 1,154
h-index 17
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0001-7916-972X

Waseem Hajjar is a researcher affiliated with King Saud University, Saudi Arabia. The supplied academic profile identifies 76 documents, 1,154 citations, and an h-index of 17. His scholarly identity is additionally represented through persistent ORCID, Scopus, and Google Scholar profiles. The Innovative Research Award profile presented here summarizes the supplied bibliometric and institutional information in a neutral academic format.

Abstract

Waseem Hajjar is a clinical medicine researcher affiliated with King Saud University, Saudi Arabia, whose scholarly record includes 76 indexed documents, 1,154 citations, and an h-index of 17 according to the supplied profile data. His research portfolio reflects sustained engagement with clinical research and scholarly communication. The Innovative Research Award profile recognizes his documented research activity, publication record, citation impact, and professional presence across academic platforms. His ORCID, Scopus, and Google Scholar identifiers provide persistent links for verification and facilitate discovery of his scholarly contributions. This page summarizes the supplied academic information and presents it in a neutral format internationally.

Keywords

Clinical medicine; clinical research; medical research; healthcare research; evidence-based medicine; biomedical research; academic publishing; research collaboration; scholarly communication; research impact; citation analysis; Scopus; ORCID; Google Scholar; King Saud University; Saudi Arabia; innovative research; medical science; health sciences.

Introduction

Waseem Hajjar’s academic profile is presented within the context of clinical medicine and scholarly research. The supplied information identifies King Saud University as his institutional affiliation and Saudi Arabia as his country. Bibliometric indicators provide a concise description of indexed research activity, while persistent identifiers enable readers to distinguish and verify the researcher’s scholarly record across major academic platforms. Scopus provides author-level indexing and citation information, whereas ORCID supplies a persistent researcher identifier.

Research Profile

Waseem Hajjar is affiliated with King Saud University in Saudi Arabia and is identified in Scopus by author ID 35518559800. The supplied profile records 76 documents, 1,154 citations, and an h-index of 17. His identifiers across Scopus and ORCID support consistent attribution and scholarly profile discovery within academic databases internationally. These platforms provide complementary approaches to discovering publications, citations, author identifiers, and scholarly outputs. Bibliographic databases may differ in coverage and indexing practices, so individual records should be consulted when precise publication-level information is required. [1]

Research Contributions

Waseem Hajjar’s research contributions can be described through documented publication activity in clinical medicine and the associated citation record. Metrics indicate sustained scholarly output rather than one contribution. Interpretation of research themes should rely on individual publications, methodologies, findings, clinical contexts, and independently documented evidence from relevant literature and sources. Assessment of clinical research contributions generally requires consideration of study design, methodological rigor, reproducibility, clinical relevance, and the extent to which findings contribute to established knowledge.  [2]

Publications

Waseem Hajjar’s publication record contains 76 documents in the supplied Scopus profile. These publications provide evidence to evaluate research themes, methods, collaborations, and clinical relevance. Because publication titles and bibliographic details were not supplied here, this section avoids assigning topics and instead directs readers to the author record for verification. The supplied document count should be understood as a database-specific indicator rather than a complete inventory of every scholarly output.  [1]

Research Impact

Waseem Hajjar’s supplied citation indicators include 1,154 citations and an h-index of 17. These measures provide quantitative descriptions of scholarly visibility within the indexed record, while interpretation depends on field, publication age, database coverage, collaboration patterns, and citation practices. They should therefore be considered alongside publication-level evidence and contextual assessment. Citation indicators are commonly used to describe patterns of scholarly attention, but they have recognized limitations. [3]

Award Suitability

Waseem Hajjar’s profile contains identifiable academic credentials, indexed publications, citation indicators, and persistent researcher identifiers relevant to consideration for an Innovative Research Award. Award suitability should be determined from documented evidence, including originality, methodological quality, research contribution, reproducibility, and relevance of individual studies, rather than from bibliometric indicators alone. For a comprehensive award assessment, individual publications and supporting evidence should be reviewed alongside the supplied profile information. [4]

Conclusion

Waseem Hajjar’s supplied academic profile documents an affiliation with King Saud University, a Scopus author record containing 76 documents, 1,154 citations, and an h-index of 17, together with persistent ORCID and Google Scholar identifiers. These details provide a structured overview of scholarly activity. More detailed evaluation should be based on the underlying publications and independently verifiable research evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Waseem Hajjar, Author ID 35518559800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=35518559800
  2. ORCID. (n.d.). Waseem Hajjar — ORCID record.
    https://orcid.org/0000-0001-7916-972X
  3. Kaaki, S., Barnawi, A. B., Robaidi, H. A., Maghrabi, A. A., Almaymuni, A. D., Alzahim, A., Almahmoud, A., Alsalem, K. A., Alshehri, Y. M., Alsharari, H. S., & Hajjar, W. M. (2026). Perioperative outcomes and safety of uniportal robotic-assisted thoracic surgery (U-RATS) for anatomic lung resection: A systematic review and meta-analysis. https://link.springer.com/article/10.1007/s11701-026-03349-x
  4. Health Scientists Awards. (n.d.). Health Scientists Awards.
    https://healthscientists.org/
  5. Google Scholar. (n.d.). Waseem Hajjar — Google Scholar profile.
    https://scholar.google.com/citations?user=7s7wbfUAAAAJ&hl=en&oi=ao

Bernd Fink | Clinical Medicine | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Bernd Fink
Affiliation Orthopaedic Clinic Markgröningen
Country Germany
Scopus ID 22943409800
Documents 176
Citations 3,339
h-index 29
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-7485-3941
Bernd Fink – Orthopaedic Clinic Markgröningen, Germany

Bernd Fink is a German orthopaedic surgeon and clinical researcher whose scholarly work primarily focuses on hip and knee arthroplasty, implant fixation, revision surgery, prosthetic joint infection, and long-term orthopedic outcomes. His scientific publications have contributed to improving evidence-based clinical practice through investigations into implant performance, surgical techniques, and patient-centered treatment strategies. His academic profile reflects sustained engagement with musculoskeletal research and international collaboration within clinical medicine.[1]

Abstract

Bernd Fink has established an internationally recognized academic profile through clinical investigations involving hip arthroplasty, knee replacement, implant fixation, revision procedures, prosthetic joint infection, biomaterials, and orthopedic outcomes. His publications emphasize evidence-based surgical decision-making, implant longevity, patient safety, and postoperative functional recovery. By integrating clinical observations with long-term follow-up studies, his research supports improvements in orthopedic practice and healthcare quality. His contributions continue influencing musculoskeletal surgery through scientifically validated findings that benefit clinicians, researchers, and patients while strengthening international orthopedic literature and advancing modern clinical medicine through collaborative multidisciplinary research worldwide.[2]

Keywords

Hip Arthroplasty, Knee Arthroplasty, Revision Arthroplasty, Prosthetic Joint Infection, Cementless Implant, Implant Fixation, Acetabular Cup, Femoral Stem, Orthopaedic Surgery, Clinical Outcomes, Total Hip Replacement, Joint Reconstruction.

Introduction

Bernd Fink investigates orthopedic surgery through clinically relevant research addressing joint replacement, revision strategies, implant fixation, infection prevention, and long-term patient outcomes. His scholarly publications integrate practical surgical experience with scientific evaluation, supporting evidence-based improvements in musculoskeletal healthcare while strengthening contemporary orthopedic knowledge through internationally recognized clinical investigations.[1]

Research Profile

Bernd Fink maintains an active research profile centered on hip arthroplasty, knee replacement surgery, prosthetic joint infection, implant survival, revision procedures, and orthopedic biomechanics. His publications demonstrate sustained collaboration with international researchers while contributing valuable clinical evidence supporting safer surgical interventions and improved patient rehabilitation across orthopedic practice.[2]

Research Contributions

Bernd Fink contributes significantly by evaluating implant performance, optimizing revision arthroplasty techniques, investigating prosthetic infections, and improving postoperative recovery through evidence-based orthopedic studies. His findings assist clinicians in selecting effective surgical approaches while promoting durable implant performance and enhanced quality of patient-centered musculoskeletal healthcare internationally.[3]

Publications

Bernd Fink has published extensively on hip arthroplasty, knee replacement, prosthetic joint infection, implant fixation, revision surgery, and long-term orthopedic outcomes. His scholarly articles emphasize evidence-based surgical practice, implant longevity, patient recovery, and clinical decision-making, providing valuable scientific knowledge that supports continuous advancements in modern orthopedic medicine worldwide.[3]

Research Impact

Bernd Fink’s research provides clinically meaningful evidence supporting orthopedic surgeons managing complex arthroplasty cases. His publications strengthen understanding of implant longevity, revision surgery, prosthetic infection prevention, and postoperative rehabilitation. These scholarly contributions continue supporting healthcare professionals seeking reliable evidence for improving orthopedic surgical quality and patient outcomes.[4]

Award Suitability

Bernd Fink demonstrates qualities consistent with recognition through the Innovative Research Award because his sustained orthopedic investigations have strengthened evidence-based clinical medicine. His scholarly contributions, publication record, international visibility, and commitment to improving arthroplasty outcomes collectively reflect meaningful scientific achievement deserving academic recognition within contemporary health sciences.[4]

Conclusion

Bernd Fink continues contributing valuable scientific knowledge through orthopedic clinical research emphasizing implant performance, revision surgery, infection management, and patient outcomes. His publications support evidence-based healthcare while promoting continuous improvements in musculoskeletal medicine. His academic achievements illustrate a sustained commitment to advancing clinical medicine through rigorous scientific investigation.[2]

References

  1. Scopus Author Profile. Bernd Fink.
    https://www.scopus.com/authid/detail.uri?authorId=22943409800
  2. ORCID. Bernd Fink Research Profile.
    https://orcid.org/0000-0002-7485-3941
  3. Fink, B., & Tetsworth, K. D. (2017). Antibiotic elution from cement spacers and its influencing factors.
    https://doi.org/10.3390/antibiotics14070705
  4. ResearchGate Profile.
    https://www.researchgate.net/profile/Bernd-Fink-3
  5. Health Scientists Awards.
    https://healthscientists.org/

Sarfaraz Niazi | Clinical Medicine | Lifetime Achievement Award

Published on by Health Scientists

Lifetime Achievement Award

Sarfaraz Niazi
Affiliation Washington State University
Country United States
Scopus ID 7004749563
Documents 156
Citations
2,572
h-index 26
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-0513-0336

Sarfaraz Niazi
Washington State University, United States

Sarfaraz Niazi is an internationally recognized pharmaceutical scientist whose scholarly work has significantly influenced pharmaceutical formulation science, manufacturing technologies, dosage form development, drug delivery systems, regulatory sciences, and pharmaceutical product commercialization. His publications, technical handbooks, and scientific contributions have been extensively utilized by academic researchers, pharmaceutical industries, regulatory professionals, and healthcare innovators worldwide. His sustained research productivity, educational publications, and practical innovations demonstrate long-term contributions to clinical medicine and pharmaceutical sciences deserving scholarly recognition.[1]

Abstract

Sarfaraz Niazi has established a distinguished academic career through influential research, authoritative pharmaceutical reference books, and practical innovations supporting drug formulation, pharmaceutical manufacturing, analytical development, quality assurance, and commercialization. His scholarly publications have contributed to improving pharmaceutical education, industrial manufacturing practices, regulatory understanding, and formulation science across diverse healthcare applications. The breadth of his scientific output, sustained international citation record, and educational influence demonstrate enduring contributions to clinical medicine and pharmaceutical sciences while supporting innovation, professional training, and evidence-based pharmaceutical development worldwide.[2]

Keywords

Pharmaceutical formulation, Drug delivery, Pharmaceutical manufacturing, Dosage forms, Preformulation, Drug development, Regulatory science, Clinical medicine, Pharmaceutical technology, Quality assurance, Drug discovery, Formulation development.

Introduction

Sarfaraz Niazi has contributed extensively to pharmaceutical sciences through multidisciplinary research integrating formulation development, manufacturing technologies, analytical methodologies, and industrial pharmaceutical practice. His scientific publications and reference books continue supporting researchers, educators, pharmaceutical manufacturers, and healthcare professionals seeking evidence-based approaches for modern pharmaceutical product development and commercialization.[3]

Research Profile

Sarfaraz Niazi has maintained an internationally recognized scholarly profile characterized by influential publications, comprehensive pharmaceutical textbooks, industrial expertise, and sustained academic engagement. His research spans pharmaceutical manufacturing, formulation optimization, regulatory sciences, dosage form technologies, and translational pharmaceutical innovation supporting healthcare advancement through scientific excellence.[1]

Research Contributions

Sarfaraz Niazi has advanced pharmaceutical sciences by developing authoritative resources addressing formulation strategies, manufacturing processes, quality systems, and commercialization pathways. His publications bridge academic knowledge with industrial implementation, strengthening pharmaceutical education while facilitating innovation in drug development, product quality, and therapeutic manufacturing technologies worldwide.[4]

Publications

Sarfaraz Niazi has authored influential books and peer-reviewed publications covering pharmaceutical preformulation, liquid dosage manufacturing, computer-aided drug discovery, pharmaceutical technologies, and industrial formulation sciences. These scholarly resources remain widely referenced within universities, pharmaceutical industries, regulatory organizations, and professional research environments internationally.[5]

Research Impact

Sarfaraz Niazi has generated enduring academic and industrial influence through publications supporting pharmaceutical innovation, formulation optimization, manufacturing quality, and educational advancement. His scholarly contributions continue assisting researchers and healthcare industries in developing effective pharmaceutical products while strengthening evidence-based pharmaceutical sciences internationally.[2]

Award Suitability

Sarfaraz Niazi demonstrates sustained scholarly excellence through influential research publications, internationally recognized pharmaceutical references, educational leadership, and practical industrial innovation. These long-term scientific achievements, combined with substantial global academic influence, strongly align with the objectives and recognition standards associated with the Lifetime Achievement Award.[1]

Conclusion

Sarfaraz Niazi has built an internationally respected scientific legacy through pharmaceutical research, industrial innovation, educational scholarship, and authoritative publications. His lasting influence across pharmaceutical sciences, clinical medicine, formulation technology, and healthcare education reflects the sustained excellence expected from recipients of distinguished international scientific recognition.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Sarfaraz Niazi, Author ID 7004749563. Scopus.
    https://www.scopus.com/pages/authors/7004749563
  2. ORCID. (n.d.). Sarfaraz Niazi ORCID Record.
    https://orcid.org/0000-0002-0513-0336
  3. Google Scholar. (n.d.). Scholar Profile: Sarfaraz Niazi.
    https://scholar.google.com/citations?user=O2dgTYIAAAAJ&hl=en&oi=ao
  4. ResearchGate. (n.d.). Sarfaraz Niazi Research Profile.
    https://www.researchgate.net/profile/Sarfaraz-Niazi-3
  5. Niazi, S. K., & Mariam, Z. (2024). Computer-aided Drug Design and Drug Discovery: A Prospective Analysis. Pharmaceuticals.
    https://doi.org/10.3390/ph17010022